Company Filing History:
2 out of 4 
2 out of 2 Years Active: 2019-2021
Title: Patricia García Fernández: Innovator in Vaccine Development
Introduction
Patricia García Fernández is a prominent inventor based in A Coruña, Spain. She has made significant contributions to the field of vaccine development, particularly through her innovative methods for producing live attenuated bacterial strains.
Latest Patents
Patricia holds two patents, with her latest focusing on live attenuated vaccines. This invention refers to a method for the production of live attenuated bacterial strains that are suitable as vaccine candidates. The process involves providing a bacterial strain capable of expressing glutamate racemase and possibly D-amino acid transaminase, followed by inactivating the genes encoding these enzymes. This inactivation results in a bacterial strain that is auxotrophic for D-glutamate, making it a potential candidate for vaccine development.
Career Highlights
Throughout her career, Patricia has worked with notable organizations, including the Servicio Galego De Saúde (Sergas) and Fundación Profesor Novoa Santos. Her work in these institutions has allowed her to advance her research and contribute to the scientific community.
Collaborations
Patricia has collaborated with esteemed colleagues such as Germán Bou Arévalo and María Clara Póvoa Cabral. These partnerships have enriched her research and fostered innovation in her field.
Conclusion
Patricia García Fernández is a trailblazer in the development of live attenuated vaccines, showcasing her dedication to advancing medical science. Her innovative methods and collaborations highlight her significant impact on vaccine research and development.